Avirulent anti-rabies vaccine
US5853735A · kind A · utility
5Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 1997 |
| Grant date | Dec 29, 1998 |
| Priority date | — |
| Expiry date | Jan 17, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/20134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an avirulent anti-rabies vaccine which consists of an avirulent mutant of an SAD strain of the rabies virus, the glycoprotein of which possesses in position 333 a naturally occurring amino acid whose codon differs from those of arginine by at least two nucleotides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.